Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamya Sankar

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Current Hematologic Malignancy Reports|August 23, 2020
Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?Kamya Sankar, Kristen Pettit
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?Kamya Sankar, Brady L Stein
Cancers|April 3, 2021
Immunotherapy for <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising ApproachesKamya Sankar, Sunitha Nagrath, Nithya Ramnath
Expert Review of Anticancer Therapy|June 26, 2020
Molecular therapeutic targets in non-small cell lung cancerKamya Sankar, Shirish M Gadgeel, Angel Qin
Cancer Treatment and Research|July 19, 2019
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative NeoplasmsKamya Sankar, Brady L Stein, Raajit K Rampal
Seminars in Oncology|July 12, 2022
Molecular biomarkers and liquid biopsies in lung cancerKamya Sankar, Mina Zeinali, Sunitha Nagrath, et al.
International Journal of Molecular Sciences|September 28, 2024
Emerging Targets in Non-Small Cell Lung CancerLouisa Liu, Joshua Soler, Karen L Reckamp, et al.
Expert Opinion on Pharmacotherapy|October 11, 2022
An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutationsGarth W Strohbehn, Kamya Sankar, Angel Qin, et al.
Scientific Reports|October 13, 2025
Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancerAlfred A Chan, Kamya Sankar, Karen L Reckamp, et al.
Biomarker Research|May 18, 2022
The role of biomarkers in personalized immunotherapyKamya Sankar, Jing Christine Ye, Zihai Li, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Hematologic Malignancy Reports|August 23, 2020
Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?Kamya Sankar, Kristen Pettit
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?Kamya Sankar, Brady L Stein
Cancers|April 3, 2021
Immunotherapy for <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising ApproachesKamya Sankar, Sunitha Nagrath, Nithya Ramnath
Expert Review of Anticancer Therapy|June 26, 2020
Molecular therapeutic targets in non-small cell lung cancerKamya Sankar, Shirish M Gadgeel, Angel Qin
Cancer Treatment and Research|July 19, 2019
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative NeoplasmsKamya Sankar, Brady L Stein, Raajit K Rampal
Seminars in Oncology|July 12, 2022
Molecular biomarkers and liquid biopsies in lung cancerKamya Sankar, Mina Zeinali, Sunitha Nagrath, et al.
International Journal of Molecular Sciences|September 28, 2024
Emerging Targets in Non-Small Cell Lung CancerLouisa Liu, Joshua Soler, Karen L Reckamp, et al.
Expert Opinion on Pharmacotherapy|October 11, 2022
An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutationsGarth W Strohbehn, Kamya Sankar, Angel Qin, et al.
Scientific Reports|October 13, 2025
Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancerAlfred A Chan, Kamya Sankar, Karen L Reckamp, et al.
Biomarker Research|May 18, 2022
The role of biomarkers in personalized immunotherapyKamya Sankar, Jing Christine Ye, Zihai Li, et al.
Pageof 5